Volume 2(Supplement 1):39-41

Slides:



Advertisements
Similar presentations
Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Advertisements

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
How I treat HHV8/KSHV-related diseases in posttransplant patients by Giovanni Riva, Mario Luppi, Patrizia Barozzi, Fabio Forghieri, and Leonardo Potenza.
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase–deficient children receiving dapsone by Allan Pamba, Naomi D. Richardson,
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation by Surbhi Shah, Faye L. Norby, Yvonne.
Hypocholesterolemia Is Independently Associated with Decreased Survival in Patients with Primary Myelofibrosis: An Analysis of Lipid Profiles in 558 Myeloproliferative.
by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
by Toru Takahashi, Toshiaki Yujiri, and Yukio Tanizawa
by Timothy P. Hughes, and David M. Ross
Outcomes in Patients with Chronic Myeloid Leukemia (CML) Who Are Treated with Imatinib As Front Line Therapy by Kendra L. Sweet, Najla H Al Ali, Jeffrey.
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
How I treat elderly patients with myeloma
Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,
Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer by Shruti Chaturvedi, Surbhi.
Genetic sequence analysis of inherited bleeding diseases
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
Protease inhibitors potentiate chemotherapy-induced neutropenia
How we choose factor VIII to treat hemophilia
Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients by Oluwagbemiga O. Ayoola, Rahman A.
by Sabah Sallah, and Jim Y. Wan
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,
How I treat refractory CLL
Volume 2(Supplement 1):63-66
Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the.
Low Dose Thymoglobulin Results In Improved Outcomes After Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) For Patients With Acute Myeloid.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Laboratory capacity-building initiative to assess folate status in women of reproductive age from Haryana, India: the collaborative experience of local.
Activity of eltrombopag in severe aplastic anemia
Immunotherapy for acute lymphoblastic leukemia: from famine to feast
Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma by Young Ae Kim, Ja Min Byun, Keeho Park, Gi Hwan Bae, Dukhyoung.
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study by C. Madsen, M. R. Clausen, T. L. Plesner,
Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial by Ersi Voskaridou,
by Alex Aleshin, and Peter L. Greenberg
Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.
Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions by Priyanka Pandey, Waseem Q. Anani,
by J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A
Volume 2(Supplement 1):8-10
by Kaiwen Chen, Matthew P. Cheng, Sarah P
by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc
Volume 2(Supplement 1):1-3
Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.
Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.
by Mieke Aldenhoven, Brigitte T. A. van den Broek, Robert F
Plasma biomarker concentrations between study groups.
by Christine L. Kempton, and Amanda B. Payne
Volume 2(Supplement 1):46-49
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis by Samuel Yamshon,
by Giovanni Palladini, and Giampaolo Merlini
Volume 2(Supplement 1):14-16
by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry by Donald M. Arnold, Ishac Nazy, Rumi.
Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study by Hesham M. Eissa, Lu Lu, Malek Baassiri,
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis by Rasha Khatib, Maja Ludwikowska, Daniel.
The journey of stem cell transplantation in Bangladesh: a hike to the state of the art with collaboration between DMCH and MGH by Mafruha Akter, Mohiuddin.
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.
Resistance mechanism for ibrutinib in marginal zone lymphoma
Impact of age on clinical risk scores in follicular lymphoma
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera by Nikolai A. Podoltsev, Mengxin.
by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio
Balancing bleeding in brain metastases
Volume 2(Supplement 1):4-7
Cold agglutinin disease
New concepts for anticoagulant therapy in persons with hemophilia
Presentation transcript:

Volume 2(Supplement 1):39-41 Hemophilia in the developing world: transforming lives through international collaboration by A. Jandial, K. Mishra, R. Sandal, N. Jindal, D. Goni, D. Lad, G. Prakash, A. Khadwal, J. Ahluwalia, N. Varma, and P. Malhotra BloodAdv Volume 2(Supplement 1):39-41 November 30, 2018 © 2018 by The American Society of Hematology

The catchment area of PGIMER Chandigarh covers the states in northern India. A. Jandial et al. Blood Adv 2018;2:39-41 © 2018 by The American Society of Hematology

CFCs are kept at 4°C in a storage facility established through collaborative efforts. A. Jandial et al. Blood Adv 2018;2:39-41 © 2018 by The American Society of Hematology

A patient with hemophilia receiving intravenous factor VIII from trained staff at PGIMER Chandigarh. A. Jandial et al. Blood Adv 2018;2:39-41 © 2018 by The American Society of Hematology

Clinical profile of patients with hemophilia who have been treated with free CFCs. A. Jandial et al. Blood Adv 2018;2:39-41 © 2018 by The American Society of Hematology